198 related articles for article (PubMed ID: 38232985)
1. Immunotherapy for Ovarian Cancer: Disappointing or Promising?
Deng M; Tang F; Chang X; Liu P; Ji X; Hao M; Wang Y; Yang R; Ma Q; Zhang Y; Miao J
Mol Pharm; 2024 Feb; 21(2):454-466. PubMed ID: 38232985
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy in Ovarian Cancer.
Siminiak N; Czepczyński R; Zaborowski MP; Iżycki D
Arch Immunol Ther Exp (Warsz); 2022 Aug; 70(1):19. PubMed ID: 35941287
[TBL] [Abstract][Full Text] [Related]
3. New Approaches for Immune Directed Treatment for Ovarian Cancer.
Hardwick N; Frankel PH; Cristea M
Curr Treat Options Oncol; 2016 Mar; 17(3):14. PubMed ID: 26942589
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in ovarian cancer.
Krishnan V; Berek JS; Dorigo O
Curr Probl Cancer; 2017; 41(1):48-63. PubMed ID: 28169004
[TBL] [Abstract][Full Text] [Related]
5. Current and Future Applications of Novel Immunotherapies in Urological Oncology: A Critical Review of the Literature.
Özdemir BC; Siefker-Radtke AO; Campbell MT; Subudhi SK
Eur Urol Focus; 2018 Apr; 4(3):442-454. PubMed ID: 29056275
[TBL] [Abstract][Full Text] [Related]
6. Glioblastoma Immunotherapy: A Systematic Review of the Present Strategies and Prospects for Advancements.
Agosti E; Zeppieri M; De Maria L; Tedeschi C; Fontanella MM; Panciani PP; Ius T
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894718
[TBL] [Abstract][Full Text] [Related]
7. [Current advances in immunotherapy in ovarian cancer].
Le Saux O; Dubois B; Stern MH; Terme M; Tartour E; Classe JM; Chopin N; Trédan O; Caux C; Ray-Coquard I
Bull Cancer; 2020 Apr; 107(4):465-473. PubMed ID: 32089245
[TBL] [Abstract][Full Text] [Related]
8. Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant.
Yang C; Xia BR; Zhang ZC; Zhang YJ; Lou G; Jin WL
Front Immunol; 2020; 11():577869. PubMed ID: 33123161
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy as a New Therapeutic Approach for Brain and Spinal Cord Tumors.
Medikonda R; Pant A; Lim M
Adv Exp Med Biol; 2023; 1394():73-84. PubMed ID: 36587382
[TBL] [Abstract][Full Text] [Related]
10. Efficacy evaluation of multi-immunotherapy in ovarian cancer: From bench to bed.
Hu X; Bian C; Zhao X; Yi T
Front Immunol; 2022; 13():1034903. PubMed ID: 36275669
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapies and Combination Strategies for Immuno-Oncology.
Barbari C; Fontaine T; Parajuli P; Lamichhane N; Jakubski S; Lamichhane P; Deshmukh RR
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679922
[TBL] [Abstract][Full Text] [Related]
12. Cancer immunotherapy in clinical practice -- the past, present, and future.
Goel G; Sun W
Chin J Cancer; 2014 Sep; 33(9):445-57. PubMed ID: 25189717
[TBL] [Abstract][Full Text] [Related]
13. Emerging immunotherapies in ovarian cancer.
Ojalvo LS; Nichols PE; Jelovac D; Emens LA
Discov Med; 2015 Sep; 20(109):97-109. PubMed ID: 26463091
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy in Ovarian Cancer.
Wang W; Liu JR; Zou W
Surg Oncol Clin N Am; 2019 Jul; 28(3):447-464. PubMed ID: 31079799
[TBL] [Abstract][Full Text] [Related]
15. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
Patel A; Fong L
Oncology (Williston Park); 2018 Mar; 32(3):112-20. PubMed ID: 29548065
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy opportunities in ovarian cancer.
Chu CS; Kim SH; June CH; Coukos G
Expert Rev Anticancer Ther; 2008 Feb; 8(2):243-57. PubMed ID: 18279065
[TBL] [Abstract][Full Text] [Related]
17. Targeting PD-1/PD-L1 axis as new horizon for ovarian cancer therapy.
Khatoon E; Parama D; Kumar A; Alqahtani MS; Abbas M; Girisa S; Sethi G; Kunnumakkara AB
Life Sci; 2022 Oct; 306():120827. PubMed ID: 35907493
[TBL] [Abstract][Full Text] [Related]
18. Immunotherapy in ovarian cancer.
Odunsi K
Ann Oncol; 2017 Nov; 28(suppl_8):viii1-viii7. PubMed ID: 29232467
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy in ovarian cancer: fake news or the real deal?
Marth C; Wieser V; Tsibulak I; Zeimet AG
Int J Gynecol Cancer; 2019 Jan; 29(1):201-211. PubMed ID: 30640705
[TBL] [Abstract][Full Text] [Related]
20. Immunotherapy as a treatment for biliary tract cancers: A review of approaches with an eye to the future.
Blair AB; Murphy A
Curr Probl Cancer; 2018; 42(1):49-58. PubMed ID: 29501212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
